Publicaciones en colaboración con investigadores/as de Eli Lilly and Company (2)

2006

  1. The hypothalamus-pituitary-ovarian axis as a model system for the study of SERM effects: An overview of experimental and clinical studies

    Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs (Springer Berlin Heidelberg), pp. 103-139

2003

  1. Effect of treatment with the selective oestrogen receptor modulator LY117018-HCl on pituitary sensitivity to GnRH and subsequent ovulation

    Reproduction, Vol. 125, Núm. 4, pp. 597-606